SEC Form 4 · accession 0001179110-18-013757
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Quinn
Officer — CFO,Sr.V.P. Finance, Corp.Dev.
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 10, 2018 | P | 40,000 | $0.47 | A | 52,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 6,000 shares acquired under the Issuer's stock purchase plan on May 31, 2018 and 6,000 shares acquired under the Issuer's stock purchase plan on November 30, 2018.